DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,594,000 | +10.7% | 575,111 | +104.8% | 0.03% | +8.3% |
| Q2 2021 | $10,478,000 | +3280.0% | 280,756 | +1892.4% | 0.02% | +2300.0% |
| Q4 2020 | $310,000 | -87.4% | 14,091 | -89.7% | 0.00% | -88.9% |
| Q3 2020 | $2,465,000 | -63.7% | 136,999 | -48.7% | 0.01% | -73.5% |
| Q2 2020 | $6,788,000 | +14.2% | 267,243 | -17.4% | 0.03% | -29.2% |
| Q1 2020 | $5,942,000 | -51.6% | 323,468 | -42.0% | 0.05% | +29.7% |
| Q4 2019 | $12,284,000 | +1389.0% | 557,607 | +964.6% | 0.04% | +1133.3% |
| Q2 2019 | $825,000 | -33.6% | 52,379 | -54.9% | 0.00% | -40.0% |
| Q4 2018 | $1,242,000 | -0.4% | 116,152 | +42.1% | 0.01% | +66.7% |
| Q3 2018 | $1,247,000 | +0.7% | 81,719 | -19.1% | 0.00% | -25.0% |
| Q2 2018 | $1,238,000 | +106.3% | 101,031 | +60.9% | 0.00% | +100.0% |
| Q1 2018 | $600,000 | +566.7% | 62,777 | +108.3% | 0.00% | – |
| Q2 2016 | $90,000 | – | 30,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |